Low molecular weight heparin in the treatment of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome: five case reports

Hepatic sinusoidal obstruction syndrome (HSOS) can be caused by the intake of pyrrolizidine alkaloids (PAs). The disease has a high mortality rate, a poor prognosis and limited treatment options. Managing pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome (PA-HSOS) is a significa...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Minjie, Wang, Luyuan, Du, Xiaodong, Hao, Miaomiao, Gao, Pujun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536489/
https://www.ncbi.nlm.nih.gov/pubmed/32993424
http://dx.doi.org/10.1177/0300060520961916

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536489/
https://www.ncbi.nlm.nih.gov/pubmed/32993424
http://dx.doi.org/10.1177/0300060520961916

Ejemplares similares